Topical Immunotherapies

    January 2024 in “ Elsevier eBooks
    Cynthia Truong, Katharina S. Shaw, Kristen Lo Sicco, Jerry Shapiro
    Image of study
    TLDR Some treatments that modify the immune system might help with certain types of hair loss but haven't been explored for common hair loss alone.
    Androgenetic alopecia (AGA), the most common cause of hair loss, is believed to be influenced by follicular microinflammation. Despite this, no immune modulatory therapies have been explored for AGA alone. Topical prostaglandin analogs could potentially be used for AGA treatment. Other immune modulatory therapies, such as topical irritants and sensitizers, as well as topical and intralesional steroids, are only recommended for AGA patients who also have alopecia areata or cicatricial alopecia. The document discusses the use of these topical and intralesional immunomodulatory agents for the treatment of alopecia areata or frontal fibrosing alopecia that may occur alongside AGA.
    Discuss this study in the Community →

    Cited in this study

    33 / 33 results

    Related

    2 / 2 results